COMBINED oral contraceptives
(COCs) have been shown not to
have an increased risk of venous
thromboembolism (VTE) according
to a new large Australian systematic
review and meta-analysis.
While no increased risk of VTE
with drospirenone was seen in
prospective or case control studies,
the risk of VTE was increased in
retrospective cohort and nested
case control studies.
The difference in risk of VTE based
on the choice of progestin in COCs
is, at worst, very small in absolute
terms, the authors said.The above article was sent to subscribers in Pharmacy Daily's issue from 14 Mar 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Mar 16
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.